Safety and Preliminary Efficacy of TISA-818 Injection in Patients With Acute Respiratory Distress Syndrome

Clinical trial NCT07319351 · COMPLETED

Trial details

NCT number: NCT07319351
Sponsor: EnliTISA (Shanghai) Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome (ARDS)

Start date: 2023-10-12
Primary completion: 2025-03-25
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.